JP2012527218A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527218A5
JP2012527218A5 JP2012511093A JP2012511093A JP2012527218A5 JP 2012527218 A5 JP2012527218 A5 JP 2012527218A5 JP 2012511093 A JP2012511093 A JP 2012511093A JP 2012511093 A JP2012511093 A JP 2012511093A JP 2012527218 A5 JP2012527218 A5 JP 2012527218A5
Authority
JP
Japan
Prior art keywords
mycoplasma hyopneumoniae
vaccine
strain
disease caused
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012511093A
Other languages
English (en)
Japanese (ja)
Other versions
JP5744852B2 (ja
JP2012527218A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2010/000590 external-priority patent/WO2010132932A1/en
Publication of JP2012527218A publication Critical patent/JP2012527218A/ja
Publication of JP2012527218A5 publication Critical patent/JP2012527218A5/ja
Application granted granted Critical
Publication of JP5744852B2 publication Critical patent/JP5744852B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012511093A 2009-05-19 2010-05-19 Mycoplasmahyopneumoniaeの温度感受性ワクチン株およびその使用 Active JP5744852B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009902255A AU2009902255A0 (en) 2009-05-19 Bacterial strain, vaccine and uses thereof
AU2009902255 2009-05-19
PCT/AU2010/000590 WO2010132932A1 (en) 2009-05-19 2010-05-19 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Publications (3)

Publication Number Publication Date
JP2012527218A JP2012527218A (ja) 2012-11-08
JP2012527218A5 true JP2012527218A5 (cg-RX-API-DMAC7.html) 2013-06-20
JP5744852B2 JP5744852B2 (ja) 2015-07-08

Family

ID=43125658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012511093A Active JP5744852B2 (ja) 2009-05-19 2010-05-19 Mycoplasmahyopneumoniaeの温度感受性ワクチン株およびその使用

Country Status (17)

Country Link
US (1) US8524252B2 (cg-RX-API-DMAC7.html)
EP (1) EP2453913B1 (cg-RX-API-DMAC7.html)
JP (1) JP5744852B2 (cg-RX-API-DMAC7.html)
KR (1) KR101734590B1 (cg-RX-API-DMAC7.html)
CN (1) CN102458462B (cg-RX-API-DMAC7.html)
AU (1) AU2010251761B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1010679B1 (cg-RX-API-DMAC7.html)
CA (1) CA2762587C (cg-RX-API-DMAC7.html)
CL (1) CL2011002923A1 (cg-RX-API-DMAC7.html)
DK (1) DK2453913T3 (cg-RX-API-DMAC7.html)
EA (1) EA021102B1 (cg-RX-API-DMAC7.html)
ES (1) ES2579935T3 (cg-RX-API-DMAC7.html)
MX (1) MX2011012362A (cg-RX-API-DMAC7.html)
NZ (1) NZ596722A (cg-RX-API-DMAC7.html)
PE (1) PE20120909A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010132932A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201109185B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012013409A (es) * 2010-05-19 2013-03-07 Bioproperties Pty Ltd Metodos relacionados a un micoplasma atenuado.
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体,转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
AU2013370982C9 (en) 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
EP2913947B1 (en) * 2014-02-27 2019-11-27 ADVA Optical Networking SE Passive optical network and optical line terminal
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN113278575B (zh) * 2021-07-13 2021-12-31 南华大学 一种肺炎支原体减毒突变株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
CN1100871C (zh) * 1999-06-25 2003-02-05 江苏省农业科学院畜牧兽医研究所 猪肺炎支原体克隆致弱株
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
MXPA03011924A (es) * 2001-07-02 2004-03-26 Pfizer Prod Inc Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
JP2009528361A (ja) * 2006-03-03 2009-08-06 メリアル リミテッド マイコプラズマ・ハイオニューモニエワクチン
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
DK2475384T3 (en) * 2009-09-10 2016-10-24 Merial Inc NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS
US9324223B2 (en) 2012-06-08 2016-04-26 3M Innovative Properties Company Electronic monitoring home unit and installation methods

Similar Documents

Publication Publication Date Title
Maroof et al. Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
JP2013519645A5 (cg-RX-API-DMAC7.html)
JP2009529338A (ja) 百日咳に対する単一用量ワクチンとしての生弱毒化ボルデテラ株
RU2013119946A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
Lacámara et al. MTBVAC: a tuberculosis vaccine candidate advancing towards clinical efficacy trials in TB prevention
Gong et al. Construction of a ptfA chitosan nanoparticle DNA vaccine against Pasteurella multocida and the immune response in chickens
Gong et al. Evaluation of protective efficacy of inactivated Mycoplasma synoviae vaccine with different adjuvants
HRP20150177T1 (hr) Cjepivo protiv tuberkuloze i postupak upotrebe tog cjepiva
NZ597000A (en) Compositions and methods for administration of vaccines against dengue virus
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
Deng et al. Adjuvant effects of interleukin-2 co-expression with VP60 in an oral vaccine delivered by attenuated Salmonella typhimurium against rabbit hemorrhagic disease
Zhao et al. Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo
JP2013515490A5 (cg-RX-API-DMAC7.html)
Hajam et al. Preexisting Salmonella-specific immunity interferes with the subsequent development of immune responses against the Salmonella strains delivering H9N2 hemagglutinin
AU2013351213B2 (en) Vaccine to protect a ruminant against pneumonia caused by Pasteurella multocida
JP2009209086A (ja) 粘膜投与型ワクチン
JP2017501985A (ja) PRRSおよびローソニア・イントラセルラリス(Lawsonia intracellularis)に対するブタワクチン
MX2019006831A (es) Vacuna oral contra enfermedades respiratorias de ruminantes que contiene polivinilpirrolidona.
Zhang et al. aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge
Yi et al. Age-dependent cytokine expression in response to foot-and-mouth disease virus in bovine peripheral blood mononuclear cells.
JP4554268B2 (ja) 分泌型IgA抗体誘導剤
CN101085348B (zh) 用于禽流感灭活抗原的鼻腔免疫复合佐剂
Qi et al. Immunization of pigs with Actinobacillus pleuropneumonia live attenuated (gene-deleted) vaccine HB04M intramuscularly or intranasally exhibits remarkably rapid protection against heterologous strain challenge
JP2005082581A (ja) 分泌型IgA抗体誘導剤